Novavax

YTD

ALL

Trade Novavax 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines.

CEO

John C.s Jacobs

CEOJohn C.s Jacobs

Employees

952

Employees952

Headquarters

Gaithersburg, Maryland

HeadquartersGaithersburg, Maryland

Founded

1987

Founded1987

Employees

952

Employees952

NVAX Key Statistics

Market cap

1.30B

Market cap1.30B

Price-Earnings ratio

3.67

Price-Earnings ratio3.67

Dividend yield

—

Dividend yield—

Average volume

5.13M

Average volume5.13M

High today

$8.29

High today$8.29

Low today

$7.83

Low today$7.83

Open price

$8.21

Open price$8.21

Volume

7.18M

Volume7.18M

52 Week high

$15.22

52 Week high$15.22

52 Week low

$5.01

52 Week low$5.01

NVAX News

Simply Wall St 2d

Why Novavax Is Up 7.6% After Japan Approves New Omicron Vaccine and Triggers Royalties

Novavax recently announced that a milestone payment and future royalties have been triggered through Takeda's regulatory approval in Japan for the Nuvaxovid COV...

Simply Wall St 3d

Novavax Valuation in Focus After Japanese Approval and New Royalty Stream from Takeda Deal

If you have been watching Novavax (NVAX) lately, the company’s latest announcement may have prompted a closer look. Novavax is set to receive a milestone paymen...

Analyst ratings

50%

of 8 ratings

Buy

50%

Hold

12.5%

Sell

37.5%

People also own

Based on the portfolios of people who own NVAX. This list is generated using Robinhood data, and it’s not a recommendation.